Paypa, Jenevy E.

HRN: 26-76-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2025
CEFTRIAXONE 1G (VIAL)
09/16/2025
09/23/2025
IV
2g
OD
Wound Abscess
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines